Theolytics
Latest round
- Series A
Last raised
- Jul 2021
Total raised
- $15M
Investors
- 4
About Theolytics
Founded in 2017 and based in Oxford, UK, Theolytics Limited operates as a biotechnology company. The company was founded by its CSO, Margaret Duffy. In August 2024, Theolytics Ltd. Theolytics develops and offers next-generation oncolytic viral therapies. The company's lead product candidate, THEO-260, is a next-generation oncolytic adenovirus for the treatment of ovarian cancer.
Who invested in Theolytics
4 investors across 3 rounds
See all investors in Theolytics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Theolytics
Who invested in Theolytics?
Theolytics has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Theolytics raised?
Theolytics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Theolytics last raise money?
Theolytics's most recent round on record is a Series A, in Jul 2021.
What does Theolytics do?
Founded in 2017 and based in Oxford, UK, Theolytics Limited operates as a biotechnology company.
Where is Theolytics headquartered?
Theolytics is headquartered in Oxford, UK.
Which VCs invest in companies like Theolytics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Theolytics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Theolytics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.